EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021

Ethan Kai Jun Tham iD, Darren Jun Hao Tan, Pojsakorn Danpanichkul iD, Cheng Han Ng, Nicholas Syn, Benjamin Koh, Ryan Yan Zhe Lim, Karn Wijarnpreecha iD, Magaret Li Peng Teng, Benjamin Kai Yi Nah, Benedix Kuan Loo Sim, Xianda Cheng und 8 weitere

Liver International · 2025-03 · 45 (3)

DOI: 10.1111/liv.70001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 10.02.2025. Verfasst von Ethan Kai Jun Tham und 19 weiteren Autor:innen. Beteiligte Einrichtung: Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Liver Cirrhosis, Global Burden of Disease, Liver Diseases. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim The burden of cirrhosis and other chronic liver diseases has changed in recent years due to shifts in the contributing aetiologies. We estimated the burden of cirrhosis and other chronic liver diseases, including etiological and regional differences, across 204 countries and territories from 2010 to 2021. Approach and Results We analysed temporal trends in the burden of cirrhosis and other chronic liver diseases utilising data from the Global Burden of Disease Study 2021. We estimated annual frequencies and age‐standardised rates (ASRs) of incident cases, deaths and disability‐adjusted life‐years (DALYs) by sex, country, World Health Organisation region and its contributing aetiologies. In 2021, there were an estimated 58 417 006 incident cases, 1 425 142 deaths and 46 417 777 DALYs related to cirrhosis and other chronic liver diseases. From 2010 to 2021, there was a rise in age‐standardised incidence rates (ASIRs) (APC: +0.35%) but age‐standardised death rates (ASDRs) (APC: −1.74%) and age‐standardised disability‐adjusted life‐years (ASDALYs) (APC: −1.85%) declined. Cirrhosis related to metabolic dysfunction‐associated steatohepatitis (MASH) contributed to 48 310 981 incident cases in 2021 and was largely responsible for the overall increase in ASIRs from 2010 to 2021. Cirrhosis and other chronic liver diseases related to MASH were the only aetiology with a rise in ASIR (APC: +0.86%). Age‐standardised deaths related to all aetiologies of cirrhosis and other chronic liver diseases declined during the study period. Age‐standardised deaths and DALYs related to MASH increased in the Americas, unlike all other world regions where they declined or remained stable. Conclusions Age‐adjusted deaths related to cirrhosis and other chronic liver diseases are declining. However, the age‐adjusted incidence of cirrhosis and other chronic liver diseases is increasing, driven by increases in the incidence of MASH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisGlobal Burden of DiseaseLiver DiseasesHumansMaleFemaleIncidenceMiddle AgedDisability-Adjusted Life YearsChronic DiseaseAgedAdultGlobal Health

Stichwörter der Autor:innen

chronic liver diseasecirrhosisglobal burden

Autor:innen und Institutionen

  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
  • Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore.
  • Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York, USA.
  • Division of Gastroenterology, Department of Medicine, Alexandra Hospital, Singapore, Singapore.

ORCID-Profile: Ethan Kai Jun Tham, Pojsakorn Danpanichkul, Karn Wijarnpreecha, Zixuan Zhang, Mark Muthiah, Daniel Q Huang

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Tham, E. K. J., Tan, D. J. H., Danpanichkul, P., Ng, C. H., Syn, N., Koh, B., Lim, R. Y. Z., Wijarnpreecha, K., Teng, M. L. P., Nah, B. K. Y., Sim, B. K. L., Cheng, X., Zhang, Z., Mitra, K., Nakamura, T., Takahashi, H., Loomba, R., Zheng, M. H., Muthiah, M., & Huang, D. Q. (2025). The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021. Liver International, 45(3). https://doi.org/10.1111/liv.70001

Vancouver

Tham EKJ, Tan DJH, Danpanichkul P, Ng CH, Syn N, Koh B, et al. The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021. Liver International. 2025;45(3). doi:10.1111/liv.70001

BibTeX
@article{Tham2025,
  author = {Tham, Ethan Kai Jun and Tan, Darren Jun Hao and Danpanichkul, Pojsakorn and Ng, Cheng Han and Syn, Nicholas and Koh, Benjamin and Lim, Ryan Yan Zhe and Wijarnpreecha, Karn and Teng, Magaret Li Peng and Nah, Benjamin Kai Yi and Sim, Benedix Kuan Loo and Cheng, Xianda and Zhang, Zixuan and Mitra, Kartik and Nakamura, Toru and Takahashi, Hirokazu and Loomba, Rohit and Zheng, Ming-Hua and Muthiah, Mark and Huang, Daniel Q},
  title = {The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {3},
  doi = {10.1111/liv.70001}
}
Kostenlos starten →